Insider trades › Jorey Chernett
Jorey Chernett
A corporate insider: an officer, director or owner of more than 10% of a company. Insiders report their trades to the SEC on Form 4The form insiders use to report each purchase or sale of their company's stock. It is due within two business days of the trade. · Last filing Nov 13, 2026
Ask your AI about this
Connect Claude, ChatGPT, Gemini or Grok (Microsoft 365 Copilot coming soon) to 13F.ai and ask in plain English. Copy a question to get started:
Using 13F.ai, list Jorey Chernett's open-market buys and sells across companies in the last two years, with the Form 4 links.
Using 13F.ai, how did the stocks Jorey Chernett bought perform after the purchase compared with the S&P 500?
Using 13F.ai, are other insiders at the same companies buying or selling at the same time as Jorey Chernett?
Connect your AI · Plans and the 7-day free trial (card required)
Buying and selling by quarter
Dollars bought and sold on the open market over the last two years.
Bought Sold
By trade date, using the shares and price reported for each trade. Stock grants, option exercises and shares withheld for tax are left out.
Roles
The companies where this person reports as an insider, and their position at each, most recent first.
Latest open-market trades
Purchases and sales at every company, most recent filing first.
| How the stock has done since the trade date, measured against the S&P 500 over the same days. It describes the stock, not the trader's actual gain or loss. | Filing | ||||||
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | STIM Neuronetics, Inc. | Sale | 2.19M | $1.15 | $2.5M | — | Form 4 ↗ |
| Nov 13, 2026 | XGN Exagen Inc. | Sale | 58,068 | $4.08 | $236.9K | — | Form 4 ↗ |
| Nov 12, 2026 | XGN Exagen Inc. | Sale | 109,436 | $4.65 | $508.9K | -6.0% | Form 4 ↗ |
| Nov 12, 2026 | STIM Neuronetics, Inc. | Sale | 706,840 | $1.43 | $1.0M | -2.4% | Form 4 ↗ |
| Nov 11, 2026 | STIM Neuronetics, Inc. | Sale | 86,757 | $1.61 | $139.7K | -13.5% | Form 4 ↗ |
| Nov 9, 2026 | STIM Neuronetics, Inc. | Buy | 40,000 | $1.99 | $79.6K | -36.5% | Form 4 ↗ |
| Nov 9, 2026 | STIM Neuronetics, Inc. | Sale | 103,959 | $2.06 | $214.2K | -36.5% | Form 4 ↗ |
| Nov 6, 2026 | STIM Neuronetics, Inc. | Sale | 250,804 | $2.39 | $599.4K | -37.9% | Form 4 ↗ |
| Nov 11, 2026 | XGN Exagen Inc. | Buy | 71,315 | $5.23 | $373.0K | -17.3% | Form 4 ↗ |
| Nov 10, 2026 | XGN Exagen Inc. | Buy | 7,085 | $5.26 | $37.3K | -22.1% | Form 4 ↗ |
| Nov 9, 2026 | STLN Starling Oncology, Inc. | Buy | 48,294 | $3.65 | $176.3K | -12.7% | Form 4 ↗ |
| Nov 9, 2026 | XGN Exagen Inc. | Buy | 8,500 | $6.35 | $54.0K | -42.1% | Form 4 ↗ |
| Nov 6, 2026 | STLN Starling Oncology, Inc. | Sale | 2.85M | $3.99 | $11.4M | -5.9% | Form 4 ↗ |
| Nov 6, 2026 | XGN Exagen Inc. | Sale | 11,265 | $6.14 | $69.2K | -31.5% | Form 4 ↗ |
| Oct 30, 2026 | STIM Neuronetics, Inc. | Buy | 18,000 | $2.27 | $40.9K | -38.0% | Form 4 ↗ |
| Oct 19, 2026 | XGN Exagen Inc. | Buy | 14,000 | $7.46 | $104.4K | -42.8% | Form 4 ↗ |
| Aug 14, 2026 | STLN Starling Oncology, Inc. | Buy | 12,000 | $6.54 | $78.5K | -42.9% | Form 4 ↗ |
| Aug 14, 2026 | STIM Neuronetics, Inc. | Buy | 14,000 | $3.16 | $44.2K | -55.0% | Form 4 ↗ |
| Jul 21, 2026 | TOI Starling Oncology, Inc. | Buy | 18,000 | $5.27 | $94.9K | -36.4% | Form 4 ↗ |
| Jul 14, 2026 | STIM Neuronetics, Inc. | Buy | 35,000 | $1.78 | $62.3K | -21.8% | Form 4 ↗ |
| Jul 10, 2026 | TOI Starling Oncology, Inc. | Buy | 15,000 | $5.85 | $87.8K | -40.5% | Form 4 ↗ |
| Jun 23, 2026 | TOI Starling Oncology, Inc. | Buy | 18,000 | $5.02 | $90.4K | -33.3% | Form 4 ↗ |
| Jun 4, 2026 | TOI Starling Oncology, Inc. | Buy | 12,000 | $4.75 | $57.0K | -25.8% | Form 4 ↗ |
| May 20, 2026 | TOI Starling Oncology, Inc. | Buy | 33,500 | $4.07 | $136.3K | -18.4% | Form 4 ↗ |
| May 19, 2026 | TOI Starling Oncology, Inc. | Buy | 5,000 | $4.05 | $20.3K | -17.4% | Form 4 ↗ |
| May 19, 2026 | TOI Starling Oncology, Inc. | Buy | 30,000 | $4.09 | $122.7K | -17.4% | Form 4 ↗ |
| May 19, 2026 | STIM Neuronetics, Inc. | Buy | 100,000 | $1.17 | $117.0K | +15.0% | Form 4 ↗ |
| May 12, 2026 | STIM Neuronetics, Inc. | Buy | 475,000 | $1.34 | $636.5K | +7.3% | Form 4 ↗ |
| Apr 21, 2026 | STIM Neuronetics, Inc. | Buy | 100,000 | $1.51 | $151.0K | -14.5% | Form 4 ↗ |
| Apr 20, 2026 | STIM Neuronetics, Inc. | Buy | 100,000 | $1.58 | $158.0K | -18.5% | Form 4 ↗ |
| Apr 17, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 40,000 | $2.54 | $101.6K | -73.5% | Form 4 ↗ |
| Apr 14, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 20,000 | $2.60 | $52.0K | -76.7% | Form 4 ↗ |
| Apr 9, 2026 | TOI Starling Oncology, Inc. | Buy | 20,000 | $3.10 | $62.0K | +1.6% | Form 4 ↗ |
| Apr 7, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 60,000 | $2.93 | $175.8K | -86.0% | Form 4 ↗ |
| Apr 3, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 90,000 | $2.82 | $253.8K | -87.5% | Form 4 ↗ |
| Mar 30, 2026 | STIM Neuronetics, Inc. | Buy | 385,442 | $1.25 | $481.8K | -9.9% | Form 4 ↗ |
| Mar 27, 2026 | TOI Starling Oncology, Inc. | Buy | 27,429 | $2.96 | $81.2K | -0.7% | Form 4 ↗ |
| Mar 27, 2026 | STIM Neuronetics, Inc. | Buy | 500,000 | $1.35 | $675.0K | -11.2% | Form 4 ↗ |
| Mar 26, 2026 | STIM Neuronetics, Inc. | Buy | 25,000 | $1.44 | $36.0K | -12.4% | Form 4 ↗ |
| Mar 26, 2026 | TOI Starling Oncology, Inc. | Buy | 50,000 | $3.15 | $157.5K | -4.0% | Form 4 ↗ |
| Mar 25, 2026 | STIM Neuronetics, Inc. | Buy | 125,000 | $1.40 | $175.0K | -15.6% | Form 4 ↗ |
| Mar 24, 2026 | TOI Starling Oncology, Inc. | Buy | 125,000 | $3.11 | $388.8K | -3.7% | Form 4 ↗ |
| Mar 23, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 50,000 | $2.91 | $145.5K | -85.0% | Form 4 ↗ |
| Mar 20, 2026 | STIM Neuronetics, Inc. | Buy | 169,472 | $1.41 | $239.0K | -20.5% | Form 4 ↗ |
| Mar 20, 2026 | TOI Starling Oncology, Inc. | Buy | 25,000 | $3.35 | $83.8K | -10.9% | Form 4 ↗ |
| Mar 20, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 40,000 | $2.77 | $110.8K | -84.7% | Form 4 ↗ |
| Mar 19, 2026 | STIM Neuronetics, Inc. | Buy | 450,000 | $1.33 | $598.5K | -22.6% | Form 4 ↗ |
| Mar 19, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 77,702 | $2.64 | $205.1K | -83.6% | Form 4 ↗ |
| Mar 18, 2026 | STIM Neuronetics, Inc. | Buy | 607,400 | $1.35 | $820.0K | -11.1% | Form 4 ↗ |
| Mar 17, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 83,000 | $2.56 | $212.5K | -81.3% | Form 4 ↗ |
| Mar 17, 2026 | STIM Neuronetics, Inc. | Buy | 531,000 | $1.16 | $616.0K | +1.0% | Form 4 ↗ |
| Mar 17, 2026 | TOI Starling Oncology, Inc. | Buy | 75,000 | $3.42 | $256.5K | -15.0% | Form 4 ↗ |
| Mar 16, 2026 | TOI Starling Oncology, Inc. | Buy | 60,985 | $3.29 | $200.6K | -10.1% | Form 4 ↗ |
| Mar 13, 2026 | TOI Starling Oncology, Inc. | Buy | 263,000 | $2.92 | $768.0K | +9.3% | Form 4 ↗ |
| Mar 16, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 105,848 | $2.43 | $257.2K | -82.9% | Form 4 ↗ |
| Mar 11, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 88,000 | $2.15 | $189.2K | -74.5% | Form 4 ↗ |
| Mar 6, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 45,600 | $2.00 | $91.2K | -72.1% | Form 4 ↗ |
| Mar 4, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 30,000 | $1.87 | $56.1K | -64.5% | Form 4 ↗ |
| Mar 3, 2026 | AIRS AirSculpt Technologies, Inc. | Buy | 80,000 | $1.71 | $136.8K | -62.6% | Form 4 ↗ |
Each row links to its Form 4. Since trade compares the stock’s move from the close on the trade date (or the next trading day) to its latest close with the S&P 500 over the same days, adjusted for splits and excluding dividends. It describes the stock, not what the trader made: we don’t know their purchase price, position size or later sales. A dash means the trade isn’t matched to a listed stock, or there is no closing price after it yet.
When several people report on the same filing, we list it under the first one named, so trades by someone usually listed second may be missing here. Information, not investment advice: see the disclaimer.